$EQBK

Piper Sandler raises Equity Bancshares stock price target on costs

Piper Sandler raised its price target for Equity Bancshares (NYSE:EQBK) to $53 from $52, maintaining a Neutral rating. The stock trades at $47.63, with a Fair Value estimate above the target. Piper Sandler increased its 2026 and 2027 EPS estimates, citing lower operating expenses. Equity Bancshares reported mixed Q3 results, beating profit expectations but missing on revenue. Loan growth improved, but net interest margin narrowed.

Original reporting
Published Oct 16, 2026, 2:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 2:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EQBK
Bullish
high confidence
Mentioned
$EQBK
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EQBKBullishMed
01

Why it matters

The analyst's revised outlook highlights cost discipline and fee income strength, but notes margin pressure.

02

Market read

The new target and earnings outlook could prompt short‑term buying interest in EQBK and influence sentiment toward similar regional banks.

03

What to watch

Potential headwinds from higher deposit costs and a narrowing interest margin could limit upside.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Equity Bancshares reported mixed Q3 results, with earnings beating expectations but revenue slightly below forecasts.

Company-level read

Ticker impact

$EQBKBullishHigh confidence
Context

Piper Sandler raised its price target on Equity Bancshares to $53 and lifted its FY2026‑2027 EPS estimates.

Expected impact

likely upward pressure as the market prices in the higher target and earnings outlook

Evidence & confidence

The new target is 13% above the current price and is based on improved earnings estimates, which typically drives buying interest.

Market effects

The upgrade may lift sentiment across regional banks as analysts reassess cost‑control trends.

U.S. small‑cap financials could see modest buying pressure.

Limited; impact confined to U.S. banking sector.

Counterpoint

The price target increase may be premature if net interest margin compression persists.

Key entities

  • Equity Bancshares Inc.

    U.S. regional bank (ticker EQBK) subject of the analyst upgrade.

  • Piper Sandler

    Investment bank that raised the price target and EPS estimates.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.